Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/62117
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMacLennan, A.en
dc.contributor.authorBaber, R.en
dc.date.issued2009en
dc.identifier.citationJama-journal of the American Medical Association, 2009; 302(20):2203en
dc.identifier.issn0098-7484en
dc.identifier.issn1538-3598en
dc.identifier.urihttp://hdl.handle.net/2440/62117-
dc.description.statementofresponsibilityAlastair H. MacLennan and Rodney Baberen
dc.language.isoenen
dc.publisherAmer Medical Assocen
dc.rights© 2009 American Medical Associationen
dc.subjectHumans; Ovarian Neoplasms; Estrogen Replacement Therapy; Risk Assessment; Risk Factors; Bias (Epidemiology); Femaleen
dc.titleHormone therapy use and risk of ovarian canceren
dc.typeJournal articleen
dc.identifier.rmid0020093816en
dc.identifier.doi10.1001/jama.2009.1724en
dc.identifier.pubid36750-
pubs.library.collectionObstetrics and Gynaecology publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.